Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.
This report elaborates on the current development of the Therapeutic Nuclear Medicines industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Dongcheng
Jubilant DraxImage
Lantheus
Bayer
Spectrum Pharmaceuticals
International Isotopes
Q BioMed
Curium Pharmaceuticals
China Isotope & Radiation
By Type:
Iodine-131
Radium-223
Lutetium-177
Other
By Application:
Bone Metastasis
Thyroid
Other
Lymphoma
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Therapeutic Nuclear Medicines Market Overview 2018-2029
-
1.1 China Therapeutic Nuclear Medicines Industry Development Overview
-
1.2 China Therapeutic Nuclear Medicines Industry Development History
-
1.3 China Therapeutic Nuclear Medicines Industry Market Size (2018-2029)
-
1.4 China Therapeutic Nuclear Medicines Market Analysis by Type from Production Side
-
1.4.1 China Therapeutic Nuclear Medicines Production Volume, Production Value and Growth Rate of Iodine-131 (2018-2029)
-
1.4.2 China Therapeutic Nuclear Medicines Production Volume, Production Value and Growth Rate of Radium-223 (2018-2029)
-
1.4.3 China Therapeutic Nuclear Medicines Production Volume, Production Value and Growth Rate of Lutetium-177 (2018-2029)
-
1.4.4 China Therapeutic Nuclear Medicines Production Volume, Production Value and Growth Rate of Other (2018-2029)
-
1.5 China Therapeutic Nuclear Medicines Market Analysis by Application from Consumption End
-
1.5.1 China Therapeutic Nuclear Medicines Sales Volume, Sales Value and Growth Rate of Bone Metastasis (2018-2029)
-
1.5.2 China Therapeutic Nuclear Medicines Sales Volume, Sales Value and Growth Rate of Thyroid (2018-2029)
-
1.5.3 China Therapeutic Nuclear Medicines Sales Volume, Sales Value and Growth Rate of Other (2018-2029)
-
1.5.4 China Therapeutic Nuclear Medicines Sales Volume, Sales Value and Growth Rate of Lymphoma (2018-2029)
-
1.6 China Therapeutic Nuclear Medicines Market Analysis by Region
-
1.6.1 North China Therapeutic Nuclear Medicines Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Therapeutic Nuclear Medicines Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Therapeutic Nuclear Medicines Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Therapeutic Nuclear Medicines Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Therapeutic Nuclear Medicines Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Therapeutic Nuclear Medicines Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Therapeutic Nuclear Medicines Market Size and Growth Rate from 2018-2029
Chapter 2 China Therapeutic Nuclear Medicines Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Therapeutic Nuclear Medicines Market Status and Competition at home and abroad in 2023
-
2.2.2 China Therapeutic Nuclear Medicines Market Status and Competition Analysis in 2023
-
2.2.3 China Therapeutic Nuclear Medicines Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Therapeutic Nuclear Medicines Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Therapeutic Nuclear Medicines Industry Development
Chapter 3 Therapeutic Nuclear MedicinesIndustry Chain Analysis
-
3.1 Therapeutic Nuclear Medicines Industry Chain
-
3.2 Therapeutic Nuclear Medicines Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Therapeutic Nuclear Medicines Market
-
3.3 Therapeutic Nuclear Medicines Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Therapeutic Nuclear Medicines Market
Chapter 4 China Therapeutic Nuclear Medicines Market, by Type
-
4.1 China Therapeutic Nuclear Medicines Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Therapeutic Nuclear Medicines Total Production Volume and Growth Rate from Production Side
-
4.5 China Therapeutic Nuclear Medicines Production Volume and Growth Rate, by Type
-
4.5.1 China Therapeutic Nuclear Medicines Production Volume and Growth Rate of Iodine-131
-
4.5.2 China Therapeutic Nuclear Medicines Production Volume and Growth Rate of Radium-223
-
4.5.3 China Therapeutic Nuclear Medicines Production Volume and Growth Rate of Lutetium-177
-
4.5.4 China Therapeutic Nuclear Medicines Production Volume and Growth Rate of Other
Chapter 5 China Therapeutic Nuclear Medicines Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Therapeutic Nuclear Medicines Total Market Size and Growth Rate from Consumption End
-
5.5 China Therapeutic Nuclear Medicines Market Size and Growth Rate, by Application
-
5.5.1 China Therapeutic Nuclear Medicines Market Size and Growth Rate of Bone Metastasis
-
5.5.2 China Therapeutic Nuclear Medicines Market Size and Growth Rate of Thyroid
-
5.5.3 China Therapeutic Nuclear Medicines Market Size and Growth Rate of Other
-
5.5.4 China Therapeutic Nuclear Medicines Market Size and Growth Rate of Lymphoma
Chapter 6 China Therapeutic Nuclear Medicines Market, by Region
-
6.1 China Therapeutic Nuclear Medicines Production Volume and Production Value, by Region
-
6.2 China Therapeutic Nuclear Medicines Sales Volume and Sales Value, by Region
Chapter 7 North China Therapeutic Nuclear Medicines Market Analysis
-
7.1 North China Therapeutic Nuclear Medicines Market, by Type
-
7.2 North China Therapeutic Nuclear Medicines Market, by Application
Chapter 8 Central China Therapeutic Nuclear Medicines Market Analysis
-
8.1 Central China Therapeutic Nuclear Medicines Market, by Type
-
8.2 Central China Therapeutic Nuclear Medicines Market, by Application
Chapter 9 South China Therapeutic Nuclear Medicines Market Analysis
-
9.1 South China Therapeutic Nuclear Medicines Market, by Type
-
9.2 South China Therapeutic Nuclear Medicines Market, by Application
Chapter 10 East China Therapeutic Nuclear Medicines Market Analysis
-
10.1 East China Therapeutic Nuclear Medicines Market, by Type
-
10.2 East China Therapeutic Nuclear Medicines Market, by Application
Chapter 11 Northeast China Therapeutic Nuclear Medicines Market Analysis
-
11.1 Northeast China Therapeutic Nuclear Medicines Market, by Type
-
11.2 Northeast China Therapeutic Nuclear Medicines Market, by Application
Chapter 12 Southwest China Therapeutic Nuclear Medicines Market Analysis
-
12.1 Southwest China Therapeutic Nuclear Medicines Market, by Type
-
12.2 Southwest China Therapeutic Nuclear Medicines Market, by Application
Chapter 13 Northwest China Therapeutic Nuclear Medicines Market Analysis
-
13.1 Northwest China Therapeutic Nuclear Medicines Market, by Type
-
13.2 Northwest China Therapeutic Nuclear Medicines Market, by Application
Chapter 14 Company Profiles
-
14.1 Dongcheng
-
14.1.1 Dongcheng Company Profile
-
14.1.2 Dongcheng Therapeutic Nuclear Medicines Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Jubilant DraxImage
-
14.2.1 Jubilant DraxImage Company Profile
-
14.2.2 Jubilant DraxImage Therapeutic Nuclear Medicines Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Lantheus
-
14.3.1 Lantheus Company Profile
-
14.3.2 Lantheus Therapeutic Nuclear Medicines Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Bayer
-
14.4.1 Bayer Company Profile
-
14.4.2 Bayer Therapeutic Nuclear Medicines Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Spectrum Pharmaceuticals
-
14.5.1 Spectrum Pharmaceuticals Company Profile
-
14.5.2 Spectrum Pharmaceuticals Therapeutic Nuclear Medicines Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 International Isotopes
-
14.6.1 International Isotopes Company Profile
-
14.6.2 International Isotopes Therapeutic Nuclear Medicines Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Q BioMed
-
14.7.1 Q BioMed Company Profile
-
14.7.2 Q BioMed Therapeutic Nuclear Medicines Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Curium Pharmaceuticals
-
14.8.1 Curium Pharmaceuticals Company Profile
-
14.8.2 Curium Pharmaceuticals Therapeutic Nuclear Medicines Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 China Isotope & Radiation
-
14.9.1 China Isotope & Radiation Company Profile
-
14.9.2 China Isotope & Radiation Therapeutic Nuclear Medicines Market Performance
-
14.9.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Therapeutic Nuclear Medicines Industry Research Conclusions
-
15.2 Therapeutic Nuclear Medicines Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Therapeutic Nuclear Medicines Industry Market Size (2018-2029)
-
Figure China Therapeutic Nuclear Medicines Production Volume, Production Value and Growth Rate of Iodine-131 (2018-2029)
-
Figure China Therapeutic Nuclear Medicines Production Volume, Production Value and Growth Rate of Radium-223 (2018-2029)
-
Figure China Therapeutic Nuclear Medicines Production Volume, Production Value and Growth Rate of Lutetium-177 (2018-2029)
-
Figure China Therapeutic Nuclear Medicines Production Volume, Production Value and Growth Rate of Other (2018-2029)
-
Figure China Therapeutic Nuclear Medicines Sales Volume, Sales Value and Growth Rate of Bone Metastasis (2018-2029)
-
Figure China Therapeutic Nuclear Medicines Sales Volume, Sales Value and Growth Rate of Thyroid (2018-2029)
-
Figure China Therapeutic Nuclear Medicines Sales Volume, Sales Value and Growth Rate of Other (2018-2029)
-
Figure China Therapeutic Nuclear Medicines Sales Volume, Sales Value and Growth Rate of Lymphoma (2018-2029)
-
Figure North China Therapeutic Nuclear Medicines Market Size and Growth Rate from 2018-2029
-
Figure Central China Therapeutic Nuclear Medicines Market Size and Growth Rate from 2018-2029
-
Figure South China Therapeutic Nuclear Medicines Market Size and Growth Rate from 2018-2029
-
Figure East China Therapeutic Nuclear Medicines Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Therapeutic Nuclear Medicines Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Therapeutic Nuclear Medicines Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Therapeutic Nuclear Medicines Market Size and Growth Rate from 2018-2029
-
Figure Therapeutic Nuclear Medicines Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Therapeutic Nuclear Medicines Market Share by Type in 2018
-
Figure China Therapeutic Nuclear Medicines Market Share by Type in 2023
-
Figure China Therapeutic Nuclear Medicines Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Therapeutic Nuclear Medicines Production Volume and Growth Rate of Iodine-131 (2018-2023)
-
Figure China Therapeutic Nuclear Medicines Production Volume and Growth Rate of Radium-223 (2018-2023)
-
Figure China Therapeutic Nuclear Medicines Production Volume and Growth Rate of Lutetium-177 (2018-2023)
-
Figure China Therapeutic Nuclear Medicines Production Volume and Growth Rate of Other (2018-2023)
-
Figure China Therapeutic Nuclear Medicines Market Share by Application in 2018
-
Figure China Therapeutic Nuclear Medicines Market Share by Application in 2023
-
Figure China Therapeutic Nuclear Medicines Total Market Size and Growth Rate from Consumption End
-
Figure China Therapeutic Nuclear Medicines Market Size and Growth Rate of Bone Metastasis (2018-2023)
-
Figure China Therapeutic Nuclear Medicines Market Size and Growth Rate of Thyroid (2018-2023)
-
Figure China Therapeutic Nuclear Medicines Market Size and Growth Rate of Other (2018-2023)
-
Figure China Therapeutic Nuclear Medicines Market Size and Growth Rate of Lymphoma (2018-2023)
-
Table China Therapeutic Nuclear Medicines Production Volume by Region (2018-2023)
-
Table China Therapeutic Nuclear Medicines Production Volume Share by Region (2018-2023)
-
Figure China Therapeutic Nuclear Medicines Production Volume Share by Region (2018-2023)
-
Table China Therapeutic Nuclear Medicines Production Value by Region (2018-2023)
-
Table China Therapeutic Nuclear Medicines Production Value Share by Region (2018-2023)
-
Figure China Therapeutic Nuclear Medicines Production Value Share by Region (2018-2023)
-
Table China Therapeutic Nuclear Medicines Sales Volume by Region (2018-2023)
-
Table China Therapeutic Nuclear Medicines Sales Volume Share by Region (2018-2023)
-
Figure China Therapeutic Nuclear Medicines Sales Volume Share by Region (2018-2023)
-
Table China Therapeutic Nuclear Medicines Sales Value by Region (2018-2023)
-
Table China Therapeutic Nuclear Medicines Sales Value Share by Region (2018-2023)
-
Figure China Therapeutic Nuclear Medicines Sales Value Share by Region (2018-2023)
-
Table North China Therapeutic Nuclear Medicines Production Volume by Type (2018-2023)
-
Table North China Therapeutic Nuclear Medicines Production Volume Share by Type (2018-2023)
-
Figure North China Therapeutic Nuclear Medicines Production Volume Share by Type (2018-2023)
-
Table North China Therapeutic Nuclear Medicines Sales Volume by Application (2018-2023)
-
Table North China Therapeutic Nuclear Medicines Sales Volume Share by Application (2018-2023)
-
Figure North China Therapeutic Nuclear Medicines Sales Volume Share by Application (2018-2023)
-
Table Central China Therapeutic Nuclear Medicines Production Volume by Type (2018-2023)
-
Table Central China Therapeutic Nuclear Medicines Production Volume Share by Type (2018-2023)
-
Figure Central China Therapeutic Nuclear Medicines Production Volume Share by Type (2018-2023)
-
Table Central China Therapeutic Nuclear Medicines Sales Volume by Application (2018-2023)
-
Table Central China Therapeutic Nuclear Medicines Sales Volume Share by Application (2018-2023)
-
Figure Central China Therapeutic Nuclear Medicines Sales Volume Share by Application (2018-2023)
-
Table South China Therapeutic Nuclear Medicines Production Volume by Type (2018-2023)
-
Table South China Therapeutic Nuclear Medicines Production Volume Share by Type (2018-2023)
-
Figure South China Therapeutic Nuclear Medicines Production Volume Share by Type (2018-2023)
-
Table South China Therapeutic Nuclear Medicines Sales Volume by Application (2018-2023)
-
Table South China Therapeutic Nuclear Medicines Sales Volume Share by Application (2018-2023)
-
Figure South China Therapeutic Nuclear Medicines Sales Volume Share by Application (2018-2023)
-
Table East China Therapeutic Nuclear Medicines Production Volume by Type (2018-2023)
-
Table East China Therapeutic Nuclear Medicines Production Volume Share by Type (2018-2023)
-
Figure East China Therapeutic Nuclear Medicines Production Volume Share by Type (2018-2023)
-
Table East China Therapeutic Nuclear Medicines Sales Volume by Application (2018-2023)
-
Table East China Therapeutic Nuclear Medicines Sales Volume Share by Application (2018-2023)
-
Figure East China Therapeutic Nuclear Medicines Sales Volume Share by Application (2018-2023)
-
Table Northeast China Therapeutic Nuclear Medicines Production Volume by Type (2018-2023)
-
Table Northeast China Therapeutic Nuclear Medicines Production Volume Share by Type (2018-2023)
-
Figure Northeast China Therapeutic Nuclear Medicines Production Volume Share by Type (2018-2023)
-
Table Northeast China Therapeutic Nuclear Medicines Sales Volume by Application (2018-2023)
-
Table Northeast China Therapeutic Nuclear Medicines Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Therapeutic Nuclear Medicines Sales Volume Share by Application (2018-2023)
-
Table Southwest China Therapeutic Nuclear Medicines Production Volume by Type (2018-2023)
-
Table Southwest China Therapeutic Nuclear Medicines Production Volume Share by Type (2018-2023)
-
Figure Southwest China Therapeutic Nuclear Medicines Production Volume Share by Type (2018-2023)
-
Table Southwest China Therapeutic Nuclear Medicines Sales Volume by Application (2018-2023)
-
Table Southwest China Therapeutic Nuclear Medicines Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Therapeutic Nuclear Medicines Sales Volume Share by Application (2018-2023)
-
Table Northwest China Therapeutic Nuclear Medicines Production Volume by Type (2018-2023)
-
Table Northwest China Therapeutic Nuclear Medicines Production Volume Share by Type (2018-2023)
-
Figure Northwest China Therapeutic Nuclear Medicines Production Volume Share by Type (2018-2023)
-
Table Northwest China Therapeutic Nuclear Medicines Sales Volume by Application (2018-2023)
-
Table Northwest China Therapeutic Nuclear Medicines Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Therapeutic Nuclear Medicines Sales Volume Share by Application (2018-2023)
-
Table Dongcheng Company Profile
-
Table Dongcheng Therapeutic Nuclear Medicines Revenue, Price and Gross (2018-2023)
-
Table Jubilant DraxImage Company Profile
-
Table Jubilant DraxImage Therapeutic Nuclear Medicines Revenue, Price and Gross (2018-2023)
-
Table Lantheus Company Profile
-
Table Lantheus Therapeutic Nuclear Medicines Revenue, Price and Gross (2018-2023)
-
Table Bayer Company Profile
-
Table Bayer Therapeutic Nuclear Medicines Revenue, Price and Gross (2018-2023)
-
Table Spectrum Pharmaceuticals Company Profile
-
Table Spectrum Pharmaceuticals Therapeutic Nuclear Medicines Revenue, Price and Gross (2018-2023)
-
Table International Isotopes Company Profile
-
Table International Isotopes Therapeutic Nuclear Medicines Revenue, Price and Gross (2018-2023)
-
Table Q BioMed Company Profile
-
Table Q BioMed Therapeutic Nuclear Medicines Revenue, Price and Gross (2018-2023)
-
Table Curium Pharmaceuticals Company Profile
-
Table Curium Pharmaceuticals Therapeutic Nuclear Medicines Revenue, Price and Gross (2018-2023)
-
Table China Isotope & Radiation Company Profile
-
Table China Isotope & Radiation Therapeutic Nuclear Medicines Revenue, Price and Gross (2018-2023)
-
